Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday. Surrozen, Inc. (NASDAQ: SRZN) shares rose 67.3% to $0.7291 in pre-mark
Stocks look set to start Thursday’s session notably lower as traders are left to ponder the hawkish tone orchestrated by the Federal Reserve. On Wednesday, the Fed announced a 50-basis-point hike in
Novavax Inc (NASDAQ: NVAX) opened about 20% down this morning after the biotech firm announced a stock and debt offering. Novavax Inc to raise about $250 million The Gaithersburg-headquartered company
Each of these companies hit rough patches this year.

Why Is Novavax (NVAX) Stock Plunging Today?

09:50am, Thursday, 15'th Dec 2022
Novavax (NASDAQ: NVAX ) stock, a big Covid-19 vaccine play in 2020, fell 15% overnight on plans to raise $250 million in debt and equity. The plan is to offer $125 million in debt and $125 million in
Major Wall Street indices closed in the red on Wednesday despite an anticipated 50 basis points hike by the Federal Reserve as Chair Jerome Powell indicated the need for more data before the central b

Novavax Stock Is Diving After Hours: What's Going On?

09:44pm, Wednesday, 14'th Dec 2022 Benzinga
Novavax Inc (NASDAQ: NVAX) shares are trading lower in Wednesday's after-hours session after the company announced a proposed public offering. What Happened: Novavax proposed an underwritten public
Yahoo Finance Live anchor Seana Smith highlights which stock tickers are making moves in after-hours trading.
Shares of COVID-19 vaccine maker Novavax Inc. on Wednesday sank 11% after the company announced a proposed offering to sell millions of its debt and stock. The company said the proceeds could go towar
Is Novavax stock a buy after vaccine stocks surged on bullish news from Moderna? Is NVAX stock a buy right now?
A peak 38% decline in the Nasdaq Composite has set these innovative growth stocks up for a bounce-back year.
A peak 38% decline in the Nasdaq Composite has set these innovative growth stocks up for a bounce-back year.

Pfizer (PFE), BNTX's COVID-Flu Combo Jab Gets FDA Fast Track Tag

03:15pm, Monday, 12'th Dec 2022 Zacks Investment Research
The FDA grants fast-track designation to Pfizer (PFE)/BioNTech's (BNTX) early-stage combination vaccine candidate, which targets two respiratory diseases - influenza and COVID-19.

Novavax (NVAX) Down 7.6% Since Last Earnings Report: Can It Rebound?

04:30pm, Thursday, 08'th Dec 2022 Zacks Investment Research
Novavax (NVAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Novavax stock a buy after the Covid vaccine maker handily beat third-quarter sales estimates? Is NVAX stock a buy right now?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE